Practice Pearls
What can we help you find?
The importance of inpatient/outpatient (IPOP) unit induction and its role in the treatment of acute myeloid leukemia.
Experts in AML discuss the impact of outpatient treatment options on the quality of life for patients and review available consolidation treatments.
Experts in AML discuss the impact of outpatient treatment options on the quality of life for patients and review available consolidation treatments.
Review of the pharmacist’s role in outpatient care for acute myeloid leukemia.
Description of the traditional inpatient administrations versus outpatient treatment processes in acute myeloid leukemia.
Experts discuss the identification and Medical Utilization Evaluation of patients with newly diagnosed acute myeloid leukemia.
Yehuda Deutsch, MD, and Amanda Brahim, PharmD, BCOP, BCPS, BCACP, review the risks and precautions taken with the available treatments of acute myeloid leukemia (AML).
Amanda Brahim, PharmD, BCOP, BCPS, BCACP, discusses the members of her institution’s Pharmacy and Therapeutics (P&T) Committee who review acute myeloid leukemia treatments for formulary consideration.
Amanda Brahim, PharmD, BCOP, BCPS, BCACP, shares treatments included on her institution’s formulary for acute myeloid leukemia [AML], and factors that impact the addition of treatments to the formulary.
Experts in the area of acute myeloid leukemia discuss categorizing patients for treatment based on molecular testing results.
Yehuda Deutsch, MD, discusses the cytogenetic tests used in acute myeloid leukemia (AML), and the importance of waiting for these results.
Amanda Brahim, PharmD, BCOP, BCPS, BCACP, and Yehuda Deutsch, MD, review important laboratory and molecular tests used for diagnosing acute myeloid leukemia.